Navigation Links
AIT Laboratories Announces Name, Brand Identity for New Division
Date:5/18/2009

INDIANAPOLIS, May 18 /PRNewswire/ -- AIT Laboratories, which specializes in pain management, forensics, and clinical testing, is announcing that its newly created pharmaceutical testing division will be known as AIT Bioscience, LLC. Recently, AIT Laboratories announced that the division will be located at its Indianapolis, Ind. headquarters.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090518/DE18644LOGO )

"AIT Bioscience will operate under the same quality principles that I founded AIT Laboratories on 19 years ago," said AIT Laboratories President and CEO Michael A. Evans, Ph.D. "We have some of the industry's most veteran scientists leading the new division, including Ronald Shoup, Ph.D., who brings more than 30 years of leadership, entrepreneurship and scientific expertise to AIT Bioscience." Prior to joining AIT, Dr. Shoup was chief scientific officer of Bioanalytical Systems, Inc. in West Lafayette, Ind.

"Bioanalytical testing is closely aligned with what AIT Laboratories already does in terms of processes and equipment. AIT Bioscience wants to take those resources and apply them to the pharmaceutical industry in ways other CROs only wish they could," Shoup explained. "Our talent and lack of legacy systems allow us to build an organization from the ground up that caters to the client's specific needs. The goal is to work as a partner with drug developers to coordinate activities throughout the testing process and provide access to data in real time as it's produced by our laboratory."

The decision to create AIT Bioscience was based on AIT's desire to improve upon the traditional CRO model. The new company will provide clients the capability to monitor sample activity from point of collection to the final report in a completely paperless environment that assures correctness from one step to the next. Instead of addressing issues after the fact, the company aims to prevent them with novel electronic systems that reject potential deviations and errors in real time.

With a newly constructed laboratory in Indianapolis, AIT Bioscience will be fully operational by the fall of 2009.

Joining Shoup at AIT Bioscience are industry veterans with numerous years of experience in bioanalytical testing.

  • Timothy P. Grever serves as AIT Bioscience laboratory director. Grever comes to AIT Bioscience from Bioanalytical Systems, Inc. in West Lafayette, Ind., where he has held several positions over the past ten years, the most recent being director of bioanalytical operations where he led a 54-member bioanalytical team.
  • Brian D. Beato, Ph.D. serves as senior scientist, mass spectrometry. Prior to joining AIT Bioscience, Beato served as laboratory and technical manager for Covance Bioanalytical Services in Indianapolis, Ind., where he helped start up and expand a bioanalytical LC/MS/MS laboratory. Beato possesses more than 17 years of experience in quantitative pharmaceutical analysis and method development, the majority in bioanalytical LC/MS/MS.
  • Laurel Branstrator will assist AIT Bioscience as director of quality assurance GxP. She has most recently offered her expertise to the industry via her consulting firm, LEB Consulting Services. Prior to her consulting work, she served as senior director of quality assurance at Bioanalytical Systems, Inc.

AIT Bioscience partnered with Indianapolis branding firm Miles Design (www.milesdesign.com) to develop the new brand identity including the logo, marketing materials and website. Miles Design principal Josh Miles stated, "Working with AIT's new bioscience venture is very exciting for us - especially because it's an opportunity to build on a strong relationship with an existing partner. Internally, we had always hoped to 'find another AIT.' So when it actually happened, we were thrilled."

About AIT Bioscience:

AIT Bioscience, LLC, headquartered in Indianapolis, Ind., is a bioanalytical contract research organization supporting pre-clinical, Phase I, II, and III clinical trials. AIT Bioscience's mission is to create a new standard for quantitative bioanalytical analysis and drug development in support of small biotech and large Pharma companies. Learn more about AIT Bioscience at www.AITBioscience.com.

    Contact:  Raquel Bahamonde
              Executive Director of Corporate Communications
    Phone:    (317) 243-3894, ext. 476
    Cell:     (317) 308-0064
    E-mail:   rbahamonde@aitlabs.com


'/>"/>
SOURCE AIT Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets
2. Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians
3. Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers
4. Immunotech Laboratories Announces South American Strategy
5. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
6. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
7. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
8. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
9. Adecco Receives Honor From Alcon Laboratories
10. ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry
11. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Malden, MA (PRWEB) , ... February 24, 2017 ... ... disc replacement (TDR) procedures can be safely completed in an ambulatory surgery center ... and fusion (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)...  Driven by consumers, preference towards more natural ... growing categories, finds the recently published U.S. volume ... Multi-regional Market Analysis and Opportunities study by ... "Biotechnology actives are derived from natural ... for skin and hair care applications," explains ...
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
Breaking Biology Technology:
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, ... a new report, Sensors for Robotics: Technologies, Markets and Forecasts ... ... Revenues ... "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/26/2017)...  Acuity Market Intelligence today released the 2017 ...  Acuity characterizes 2017 as a "breakout" year for ... a new understanding of the potential benefits these ... identity are often perceived as threats to privacy ... of Acuity Market intelligence. "However, taken together these ...
Breaking Biology News(10 mins):